Table 2. Average declines in all-cause pneumonia mortality among children aged 2–23 months expected with the 90% coverage of PCV by income level in Brazil, Colombia, and Peru.
| Country | Estimated declines (95% CrIs) by income level
associated with 90% uptake of third dose of PCV |
||
|---|---|---|---|
| Low | Medium | High | |
| Brazil | 0.96 (0.86, 1.06) | 0.91 (0.85, 0.97) | 0.92 (0.85, 1.01) |
| Colombia | - | 0.77 (0.61, 0.98) | 0.75 (0.51, 1.07) |
| Peru | 0.62 (0.44, 0.88) | 1.04 (0.85, 1.28) | 0.90 (0.74, 1.10) |
The outcome for Brazil and Peru is J12-J18 coded as either primary or non-primary causes of death. The outcome for Colombia is J12-J18 coded as the primary cause of death.
Abbreviations: PCV, pneumococcal conjugate vaccine; CrI, credible interval.